The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Megace 40 mg/ml Oral Suspension



Bausch Health Ireland LimitedPA22698/024/001

Main Information

Trade NameMegace 40 mg/ml Oral Suspension
Active SubstancesMegestrol acetate
Dosage FormOral suspension
Licence HolderBausch Health Ireland Limited
Licence NumberPA22698/024/001

Group Information

ATC CodeL02AB Progestogens
L02AB01 megestrol

Status

License statusAuthorised
Licence Issued10/12/1998
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back